Treatment Planning for the CyberKnife® System Now Up to 40% Faster Read more about Treatment Planning for the CyberKnife® System Now Up to 40% Faster
Accuray Generated $55.6 Million in First Quarter Gross Orders; Revenue Increased 5 Percent Year over Year Read more about Accuray Generated $55.6 Million in First Quarter Gross Orders; Revenue Increased 5 Percent Year over Year
Accuray Incorporated Reports Inducement Grant Under NASDAQ Listing Rules Read more about Accuray Incorporated Reports Inducement Grant Under NASDAQ Listing Rules
10-year Data Shows CyberKnife® System Provides Excellent Long-term Control of Low-Risk Prostate Cancer Read more about 10-year Data Shows CyberKnife® System Provides Excellent Long-term Control of Low-Risk Prostate Cancer
Accuray Showcases CyberKnife® and Radixact™ Systems at ASTRO 2017 Read more about Accuray Showcases CyberKnife® and Radixact™ Systems at ASTRO 2017
Accuray Reports Fourth Quarter and Fiscal 2017 Financial Results Read more about Accuray Reports Fourth Quarter and Fiscal 2017 Financial Results
Summit Cancer Center-Boise Treats Its First Cancer Patients Using the Accuray Radixact™ System Read more about Summit Cancer Center-Boise Treats Its First Cancer Patients Using the Accuray Radixact™ System
Accuray To Report Fiscal 2017 Fourth Quarter And Full Year Results On August 22, 2017 Read more about Accuray To Report Fiscal 2017 Fourth Quarter And Full Year Results On August 22, 2017
First Radixact™ System Research Results Presented at the American Association of Physicists in Medicine Annual Meeting Read more about First Radixact™ System Research Results Presented at the American Association of Physicists in Medicine Annual Meeting
Accuray Receives 510(k) Clearance for iDMS™ Data Management System Upgrade for the TomoTherapy® System Read more about Accuray Receives 510(k) Clearance for iDMS™ Data Management System Upgrade for the TomoTherapy® System
